ATE355288T1 - Verbindungen und therapeutische methoden - Google Patents

Verbindungen und therapeutische methoden

Info

Publication number
ATE355288T1
ATE355288T1 AT00926538T AT00926538T ATE355288T1 AT E355288 T1 ATE355288 T1 AT E355288T1 AT 00926538 T AT00926538 T AT 00926538T AT 00926538 T AT00926538 T AT 00926538T AT E355288 T1 ATE355288 T1 AT E355288T1
Authority
AT
Austria
Prior art keywords
compounds
therapeutic methods
treatment
diseases
methods
Prior art date
Application number
AT00926538T
Other languages
English (en)
Inventor
Rodney W Rickards
Geoffrey D Smith
Kiaran Kirk
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ0373A external-priority patent/AUPQ037399A0/en
Priority claimed from AUPQ0506A external-priority patent/AUPQ050699A0/en
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE355288T1 publication Critical patent/ATE355288T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00926538T 1999-05-14 2000-05-12 Verbindungen und therapeutische methoden ATE355288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0373A AUPQ037399A0 (en) 1999-05-14 1999-05-14 Novel compounds and therapeutic methods
AUPQ0506A AUPQ050699A0 (en) 1999-05-21 1999-05-21 Novel compounds and therapeutic methods-ii

Publications (1)

Publication Number Publication Date
ATE355288T1 true ATE355288T1 (de) 2006-03-15

Family

ID=25646057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926538T ATE355288T1 (de) 1999-05-14 2000-05-12 Verbindungen und therapeutische methoden

Country Status (7)

Country Link
US (1) US6632822B1 (de)
EP (1) EP1178988B1 (de)
JP (1) JP2002544275A (de)
AT (1) ATE355288T1 (de)
CA (1) CA2372032A1 (de)
DE (1) DE60033649D1 (de)
WO (1) WO2000069856A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060067977A1 (en) * 2004-09-28 2006-03-30 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811933B1 (de) 2004-09-28 2016-03-23 Atrium Medical Corporation Barriereschicht
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (de) 2006-11-06 2013-03-27 Atrium Medical Corporation Beschichtetes chirurgisches netz
LT2975024T (lt) 2009-06-10 2018-06-11 Chugai Seiyaku Kabushiki Kaisha Tetraciklininiai junginiai
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
EP3698788A1 (de) 2010-08-20 2020-08-26 Chugai Seiyaku Kabushiki Kaisha Zusammensetzung umfassend eine tetrazyklische verbindung
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
JP5759568B2 (ja) 2012-09-25 2015-08-05 中外製薬株式会社 Ｒｅｔ阻害剤
RU2016146119A (ru) 2014-04-25 2018-05-29 Чугаи Сейяку Кабусики Кайся Новый кристалл тетрациклического соединения
BR112016021206B1 (pt) 2014-04-25 2022-07-12 Chugai Seiyaku Kabushiki Kaisha Composição farmacêutica, contendo composto tetracíclico em dose elevada e seu método de produção
TWI765410B (zh) 2014-08-08 2022-05-21 日商中外製藥股份有限公司 ４環性化合物的非晶質體的用途
WO2016114375A1 (ja) 2015-01-16 2016-07-21 中外製薬株式会社 併用医薬
KR20210024541A (ko) 2018-06-29 2021-03-05 추가이 세이야쿠 가부시키가이샤 난용성의 염기성 약제를 함유하는 의약 조성물
KR102635225B1 (ko) 2018-09-04 2024-02-07 추가이 세이야쿠 가부시키가이샤 4환성 화합물의 제조방법
CN119326763B (zh) * 2024-10-28 2025-10-28 中南大学 7H-吲哚[2,3-j]菲啶-7,13(8H)-二酮用作JAK2抑制剂以及用于制备缓解、治疗胰腺癌的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001515839A (ja) 1997-07-18 2001-09-25 ジョージタウン・ユニバーシティ 二環式向代謝性グルタミン酸受容体リガンド
CA2386441A1 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists

Also Published As

Publication number Publication date
EP1178988A4 (de) 2004-10-06
EP1178988B1 (de) 2007-02-28
CA2372032A1 (en) 2000-11-23
JP2002544275A (ja) 2002-12-24
DE60033649D1 (de) 2007-04-12
WO2000069856A1 (en) 2000-11-23
EP1178988A1 (de) 2002-02-13
US6632822B1 (en) 2003-10-14

Similar Documents

Publication Publication Date Title
DE60033649D1 (de) Verbindungen und therapeutische methoden
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
EP0939627A4 (de) Pentafluorobenzensulfonamide und analoge
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
YU13301A (sh) Muskarinski agonisti i antagonisti
ES2144054T3 (es) Complejos de tri(platino).
SE0003476D0 (sv) Compounds
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
ATE187956T1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
ATE306283T1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
ATE404550T1 (de) Chemische verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties